A chemist based at the University of Copenhagen has just taken out a patent for a drug that can make previously multidrug-resistant bacteria responsive to antibiotics once again.
Jørn Bolstad and his chemist colleagues hope that the substance will soon be able to tackle the tremendous problems associated with multidrug resistant tuberculosis (MDR-TB). But first, they need to find investors interested in getting the substance onto the market.
Before the development of penicillin, people dropped like flies in response to minor infections: in the lungs, in small cuts. Even pimples could grow to boils that killed. But one of the main killers prior to the discovery of antibiotics was tuberculosis.
The deadly infectious disease that typically affects the lungs has returned. It has developed a resistance to the majority of antibiotics that would otherwise kill the tuberculosis bacteria. Currently, the disease does not pose an imminent threat to Denmark or the West. However, resistant strains of the bacteria are nearing the region’s borders. This is one of the reasons why doctors around the world are busy trying to solve the problem of drug resistance.
The bacteria shed killing substances
While those bacteria that have developed a resistance remain vulnerable to antibiotics, they have developed an ability to shed bacteria killing substances before any damage is done to them. Colloquially, this is referred to as pooping the substance out, but the scientific formulation is that these bacteria activate an efflux pump.
Jørn Bolstad Christensen has isolated a substance able to block the efflux pump so that an antibiotic remains in bacteria until the bacteria dies.
You could say that we cure bacteria of their resistance, and slay them with antibiotics, explains Associate Professor Jørn Bolstad Christensen.
From antipsychotic to killing bacteria
Working with doctors Jette Kristiansen from the University of Southern Denmark and Oliver Hendricks from the King Christian X’s Hospital for Rheumatic Diseases in Gråsten, Denmark, Jørn Bolstad Christensen discovered that Thioridazin, an antipsychotic drug, was able to kill bacteria without any noticeably harmful effects upon humans. Still, the chemists had an idea that could make the substance more benign.
We now have a substance that is able to block the bacteria’s efflux pump. At very most, recipients of the medication may become slightly sluggish. This is also because very small doses are needed to affect the bacteria, says Jørn Bolstad Christensen.
Researchers hope for quick approval
Because Thioridazin is an approved drug, the research team hopes that the new anti-resistance medication, JEK 47, will be approved without going through the entire process that new pharmaceuticals are typically subjected to. If this is the case, JEK 47 will most likely be a cheap medication that a pharmaceuticals manufacturer could release quickly. However if an investor does not show interest, Christensen is certain about his next step.
The Latest on: Antibiotic resistance
via Google News
The Latest on: Antibiotic resistance
- Women are often prescribed the wrong antibiotics for UTIs — and for too longon February 25, 2021 at 9:30 am
Doctors are prescribing the wrong antibiotics to U.S. women nearly half the time, according to a data analysis of 670,400 patients diagnosed with UTIs. Additionally, more than 75% of the patients ...
- University of Qld researchers find artificial sweeteners may promote antibiotic resistanceon February 25, 2021 at 4:02 am
Common artificial sweeteners used in diet drinks, chewing gum, low calorie yoghurts and many other foods may be speeding up the spread of antibiotic resistance, Queensland researchers warn.
- Bacteriophage therapy could fight drug-resistant Klebsiella pneumoniaeon February 24, 2021 at 9:14 am
Using viruses instead of antibiotics to tame troublesome drug-resistant bacteria is a promising strategy, known as bacteriophage or “phage therapy.” ...
- Engineered viruses can fight the rise of antibiotic-resistant bacteriaon February 24, 2021 at 7:41 am
As the world fights the SARS-CoV-2 virus causing the COVID-19 pandemic, another group of dangerous pathogens looms in the background. The threat of antibiotic-resistant bacteria has been growing for ...
- Doctors treat female UTIs with wrong antibiotics nearly half the time, study findson February 24, 2021 at 7:00 am
Urinary track infections are painful, frustrating and all too frequent in women of all ages (and some men, too). Doctors are prescribing the wrong antibiotics to treat them, as well as giving out too ...
- Glyphosate and Other Weed Killers Create Antibiotic Resistant Bacteria in Agricultural Soilson February 23, 2021 at 8:02 pm
Soil sprayed with weedkillers glyphosate, glufosinate, or dicamba are likely to contain higher amounts of antibiotic resistant bacteria, according to research published earlier this month in the ...
- Researchers Unveil Application of Artificial Intelligence to Diagnose Antibiotic Resistanceon February 22, 2021 at 4:19 pm
In an article published in the journal Nature Communications on February 19, 2021, researchers from the University of Évry, CEA, CNRS, APHP, CHU Henri Mondor and Médecins Sans Frontières (MSF) ...
- Common weed killers favor antibiotic resistant bacteria, new study showson February 19, 2021 at 3:22 pm
The use of weed killers can increase the prevalence of antibiotic resistant bacteria in soil, a new study from the University of York shows.Herbicides are o ...
- Grant to help fill gaps in how livestock manure management affects antibiotic resistanceon February 16, 2021 at 9:09 am
Iowa State University researchers received a $1 million grant to study how manure management systems in livestock production may give rise to antibiotic resistance. Human, animal and environmental ...
- Beating the resistance: WVU scientists target antibiotic-resistant infections with $1.4M DOD granton February 15, 2021 at 11:21 am
It’s a national security threat, as the Department of Defense has tapped a team of West Virginia University scientists to help exterminate the enemy – infectious biological agents. With the aid of $1.
via Bing News